enow.com Web Search

  1. Ads

    related to: side effects of hemophilia treatment

Search results

  1. Results from the WOW.Com Content Network
  2. Marstacimab - Wikipedia

    en.wikipedia.org/wiki/Marstacimab

    Marstacimab, sold under the brand name Hympavzi, is a monoclonal antibody medication used for the treatment of hemophilia A and hemophilia B. [1] [4] [2] It is a tissue factor pathway inhibitor (TFPI) antagonist. [4] It was developed by Pfizer. [5]

  3. Recombinant factor VIIa - Wikipedia

    en.wikipedia.org/wiki/Recombinant_factor_VIIa

    The most common side effects with Novoseven include venous thromboembolic events (problems caused by blood clots in the veins), rash, pruritus (itching), urticaria (hives), fever and reduced effectiveness of treatment. [4] The most common side effects with Cevenfacta include injection site discomfort and hematoma (a collection of blood under ...

  4. Acquired haemophilia - Wikipedia

    en.wikipedia.org/wiki/Acquired_haemophilia

    Acquired haemophilia A (AHA) is a rare but potentially life-threatening bleeding disorder characterized by autoantibodies directed against coagulation factor VIII.These autoantibodies constitute the most common spontaneous inhibitor to any coagulation factor and may induce spontaneous bleeding in patients with no previous history of a bleeding disorder.

  5. FDA Approves Pfizer's Second Hemophilia Drug With Six Months

    www.aol.com/fda-approves-pfizers-second...

    Hympavzi is the first and only anti-tissue factor pathway inhibitor (anti-TFPI) approved in the U.S. for hemophilia A or B and the first hemophilia medicine approved in the U.S. to be administered via

  6. Concizumab - Wikipedia

    en.wikipedia.org/wiki/Concizumab

    Concizumab, sold under the brand name Alhemo, is a monoclonal antibody used for the treatment of hemophilia A and hemophilia B. [5] [8] It is an anti-tissue factor pathway inhibitor. [5] [8] The most common adverse reactions include injection site reactions and hives (urticaria). [11]

  7. Damoctocog alfa pegol - Wikipedia

    en.wikipedia.org/wiki/Damoctocog_alfa_pegol

    Damoctocog alfa pegol, sold under the brand name Jivi is a recombinant DNA-derived, Factor VIII concentrate used to treat hemophilia A. [5] [6] The most common side effects include headache, cough, nausea, and fever. [5] Damoctocog alfa pegol was approved for medical use in the United States in August 2018, [7] and in the European Union in ...

  8. Factor VIII (medication) - Wikipedia

    en.wikipedia.org/wiki/Factor_VIII_(medication)

    Side effects include skin flushing, shortness of breath, fever, and red blood cell breakdown. [12] [13] Allergic reactions including anaphylaxis may occur. [13] It is unclear if use during pregnancy is safe for the fetus. [14] A purified factor VIII concentrate is made from human blood plasma. [13] A recombinant version is also available. [12]

  9. Desmopressin - Wikipedia

    en.wikipedia.org/wiki/Desmopressin

    In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases. [1] It may be given in the nose, by injection into a vein, by mouth, or under the tongue. [1] Common side effects include headaches, diarrhea, and low blood sodium. [1] The low blood sodium that results may cause seizures. [1]

  1. Ads

    related to: side effects of hemophilia treatment